NA:TSXNational Bank of Canada Analysis
Data as of 2026-03-10 - not real-time
CA$185.60
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The stock is trading well above its 20‑day, 50‑day and 200‑day moving averages, with a bullish MACD crossover and an RSI comfortably in the mid‑50s, indicating upward momentum and no immediate overbought pressure. Volume is on an upward trend, the beta is below one and 30‑day volatility is moderate, suggesting the price moves are relatively insulated from broader market swings.
Fundamentally, the bank is delivering double‑digit revenue growth, strong operating margins and a solid ROE, while maintaining a healthy dividend yield with a payout comfortably below 50%. Recent earnings beat, the announcement of an expanded share‑repurchase program and the appointment of a high‑profile vice‑chair reinforce shareholder confidence, and analysts’ price targets imply modest upside.
Fundamentally, the bank is delivering double‑digit revenue growth, strong operating margins and a solid ROE, while maintaining a healthy dividend yield with a payout comfortably below 50%. Recent earnings beat, the announcement of an expanded share‑repurchase program and the appointment of a high‑profile vice‑chair reinforce shareholder confidence, and analysts’ price targets imply modest upside.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Earnings beat and upside earnings guidance
- Expanded buyback program signaling confidence
- Bullish technical setup with price above key moving averages
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue growth and strong operating margins
- Attractive dividend yield with a sustainable payout ratio
- Low beta and moderate volatility reducing market‑wide risk
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust capital position and ample cash relative to debt
- Consistent dividend policy supporting total shareholder return
- Strategic leadership additions enhancing governance and growth outlook
Key Metrics & Analysis
Financial Health
Revenue Growth24.60%
Profit Margin31.77%
P/E Ratio17.9
ROE14.34%
ROA0.78%
P/B Ratio2.3
Op. Cash FlowCA$-47511998464
Industry P/E17.4
Technical Analysis
TrendBullish
RSI60.2
SupportCA$168.81
ResistanceCA$193.71
MA 20CA$181.73
MA 50CA$174.24
MA 200CA$156.12
MACDBullish
VolumeIncreasing
Fear & Greed Index78.77
Valuation
Target PriceCA$190.64
Upside/Downside2.72%
GradeUndervalued
TypeBlend
Dividend Yield2.67%
Risk Assessment
Beta0.53
Volatility24.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.